KANTARO BIOSCIENCES
DEAD

Serial Number

88922058

Owner

Kantaro Biosciences LLC

Attorney

Michelle A. Cooke

Filing Date

May 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

KANTARO BIOSCIENCES Trademark

Serial Number: 88922058

KANTARO BIOSCIENCES is a trademark filed by Kantaro Biosciences LLC on May 18, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Kantaro Biosciences LLC (13 trademarks)

1460 Broadway
New York, NY 10036

Entity Type: 16

Trademark Details

Filing Date

May 18, 2020

Registration Date

Not Registered

Goods & Services

Medical preparations; Diagnostic agents, preparations and substances for medical or veterinary purposes; Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens and tissue; Assays, reagents, media, solutions, buffers and preparations for medical, clinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnostic agents, preparations, substances and diagnostic test kits used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical, clinical and research purposes; Kits and components for use in diagnostic testing; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood, bodily fluids, biological and cellular samples and specimens and tissue for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Antibody diagnostic test for use in disease detection; Medical test kits for coronavirus, SARS-CoV-2 and COVID-19 diagnosis and monitoring; Diagnostic preparations for medical purposes for detecting the presence of infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Preparations and substances for the diagnosis, prevention and treatment of SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jun 17, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 17, 2021 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2020 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 7, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2020 NWOS
NEW APPLICATION ENTERED
May 21, 2020 NWAP